Literature DB >> 7593878

Initial severity and differential treatment outcome in the National Institute of Mental Health Treatment of Depression Collaborative Research Program.

I Elkin1, R D Gibbons, M T Shea, S M Sotsky, J T Watkins, P A Pilkonis, D Hedeker.   

Abstract

Random regression models (RRMs) were used to investigate the role of initial severity in the outcome of 4 treatments (cognitive-behavior therapy [CBT], interpersonal psychotherapy [IPT], imipramine plus clinical management [IMI-CM], and placebo plus clinical management [PLA-CM]) for outpatients with major depressive disorder seen in the National Institute of Mental Health Treatment of Depression Collaborative Research Program. Initial severity of depression and impairment of functioning significantly predicted differential treatment effects. A larger number of differences than previously reported were found among the active treatments for the more severely ill patients; this was due, in large part, to the greater power of the present statistical analyses.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7593878     DOI: 10.1037//0022-006x.63.5.841

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  43 in total

1.  Case-finding instruments for depression. Two questions are as good as many.

Authors:  M A Whooley; A L Avins; J Miranda; W S Browner
Journal:  J Gen Intern Med       Date:  1997-07       Impact factor: 5.128

2.  Rhodiola rosea versus sertraline for major depressive disorder: A randomized placebo-controlled trial.

Authors:  Jun J Mao; Sharon X Xie; Jarcy Zee; Irene Soeller; Qing S Li; Kenneth Rockwell; Jay D Amsterdam
Journal:  Phytomedicine       Date:  2015-02-23       Impact factor: 5.340

3.  Increased prefrontal cortex activity during negative emotion regulation as a predictor of depression symptom severity trajectory over 6 months.

Authors:  Aaron S Heller; Tom Johnstone; Michael J Peterson; Gregory G Kolden; Ned H Kalin; Richard J Davidson
Journal:  JAMA Psychiatry       Date:  2013-11       Impact factor: 21.596

4.  Augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: What moderates improvement?

Authors:  Michael G Wheaton; David Rosenfield; Edna B Foa; H Blair Simpson
Journal:  J Consult Clin Psychol       Date:  2015-05-25

5.  The severity of psychiatric disorders.

Authors:  Mark Zimmerman; Theresa A Morgan; Kasey Stanton
Journal:  World Psychiatry       Date:  2018-10       Impact factor: 49.548

Review 6.  Cognitive behavioral therapy for mood disorders: efficacy, moderators and mediators.

Authors:  Ellen Driessen; Steven D Hollon
Journal:  Psychiatr Clin North Am       Date:  2010-09

7.  Improving outcome for mental disorders by enhancing memory for treatment.

Authors:  Allison G Harvey; Jason Lee; Rita L Smith; Nicole B Gumport; Steven D Hollon; Sophia Rabe-Hesketh; Kerrie Hein; Michael R Dolsen; Kirsten L Haman; Jennifer C Kanady; Monique A Thompson; Deidre Abrons
Journal:  Behav Res Ther       Date:  2016-04-02

Review 8.  The psychopathology and treatment of bipolar disorder.

Authors:  David J Miklowitz; Sheri L Johnson
Journal:  Annu Rev Clin Psychol       Date:  2006       Impact factor: 18.561

Review 9.  Cognitive therapy versus medication for depression: treatment outcomes and neural mechanisms.

Authors:  Robert J DeRubeis; Greg J Siegle; Steven D Hollon
Journal:  Nat Rev Neurosci       Date:  2008-09-11       Impact factor: 34.870

10.  Considerations regarding neuropsychiatric nutritional requirements for intakes of omega-3 highly unsaturated fatty acids.

Authors:  Joseph R Hibbeln; John M Davis
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2009-07-19       Impact factor: 4.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.